Catheter Precision, Inc. (VTAK) Research

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.

Market snapshot

Symbol
VTAK
Price
$0.84
Day change
-11.58%
Market cap
$907.6K
P/E ratio
-124.17x
52-week range
0.75-6.27
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Bone Biologics Corporation (BBLG)
  • CERo Therapeutics Holdings, Inc. (CERO)
  • PMGC Holdings Inc. (ELAB)
  • Galmed Pharmaceuticals Ltd. (GLMD)
  • HeartSciences Inc. (HSCS)
  • iSpecimen Inc. (ISPC)
  • NewGenIvf Group Limited (NIVF)
  • Tivic Health Systems, Inc. (TIVC)

Recent insider activity

  • JENKINS DAVID A — A-Award (40000 shares) on 2026-03-26
  • ANDERSON PHILIP J — A-Award (40000 shares) on 2026-03-26
  • Arno Andrew — A-Award (40000 shares) on 2026-03-26
  • Caruso James Joseph — A-Award (40000 shares) on 2026-03-26
  • COLOMBATTO MARTIN J — A-Award (40000 shares) on 2026-03-26

Open Catheter Precision, Inc. (VTAK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.